Welcome to SciMar Ltd.

SciMar is a private Manitoba company founded on the discovery of the mechanism of pre-diabetic insulin resistance (AMIS Syndrome (AMISS)) and resultant pathologies including:

• Type 2 Diabetes, 
• obesity, 
• cardiovascular and renal disease, and 
• blindness.

Our mechanistic-targeted disease management approach has led to the development of novel solutions for diagnostics, prevention, and treatment that will revolutionize this major market.